Tianjin Tianan Pharmaceutical

Tianjin Tianan Pharmaceutical is a specialized pharmaceutical company based in China, primarily focused on the development and production of treatments for diabetes and metabolic disorders. Established in 1994 and later acquired by the Luye Pharma Group, the company has become a key player in the Chinese oral hypoglycemic market. Its product portfolio includes a range of essential diabetes medications such as metformin hydrochloride, gliclazide, and acarbose, with a particular emphasis on sustained-release formulations. The company maintains modern manufacturing facilities that comply with national GMP standards to ensure high-quality production. Tianjin Tianan Pharmaceutical leverages its parent company's extensive distribution network to reach patients across China. By focusing on chronic disease management, the company continues to support the growing demand for affordable and effective endocrine therapies.